MiSeqDx Cystic Fibrosis 139-Variant Assay by Illumina

Manufacturer Illumina
MiSeqDx Cystic Fibrosis 139-Variant Assay Improved Detection Rates of CF-Causing Variants Detection of couples at risk increased from 72% to ~91%* Higher Confidence in Test Results 139-variant panel reduces residual risk Reduced Additional Testing Highly accurate and reproducible sequencing technology delivers the right answer the first time The test is intended to be used on the MiSeqDx instrument. * Compared to current ACMG recommended panelFor In Vitro Diagnostic Use. Contact an Ill... Read more


MiSeqDx Cystic Fibrosis 139-Variant Assay by Illumina product image
MiSeqDx Cystic Fibrosis 139-Variant Assay


0 Scientists have reviewed this product


Write the First Review

No Reviews

MiSeqDx Cystic Fibrosis 139-Variant Assay

  • Improved Detection Rates of CF-Causing Variants
    Detection of couples at risk increased from 72% to ~91%*
  • Higher Confidence in Test Results
    139-variant panel reduces residual risk
  • Reduced Additional Testing
    Highly accurate and reproducible sequencing technology delivers the right answer the first time

The test is intended to be used on the MiSeqDx instrument.

* Compared to current ACMG recommended panel

For In Vitro Diagnostic Use. Contact an Illumina representative for regional availability.